Literature DB >> 7682041

House dust mite allergy in Calcutta, India: evaluation by RAST.

G K Saha1.   

Abstract

A significantly elevated (above 300 U/mL) serum IgE level was found in 97 of 105 dust-sensitive asthmatic patients of Calcutta and the mean value (1002 +/- 614 U/mL) was significantly higher (P << .001) than the control sera. RAST results indicate a higher sensitivity (84.76%) to house dust and house dust mites (Dermatophagoides supp) either alone or in combination with each other. Among positive samples, 79.77%, 71.91%, and 88.76% showed the presence of allergen specific IgE antibodies against house dust (HD), D. pteronyssinus (DP), and D. farinae (DF) mite antigens, respectively. The study highlighted the superiority of D. farinae antigen as a potent allergen in house dust of Calcutta over others and the mites and house dust possibly had a common allergen. The present investigation indicates that RAST sensitivity was independent of age and sex of patients (P > .05). The frequency of RAST sensitivity was observed to be greater in patients suffering for longer durations.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7682041

Source DB:  PubMed          Journal:  Ann Allergy        ISSN: 0003-4738


  3 in total

1.  Dust mites population in indoor houses of suspected allergic patients of South assam, India.

Authors:  Dhruba Sharma; B K Dutta; A B Singh
Journal:  ISRN Allergy       Date:  2011-06-07

2.  Incrimination of Blomia tropicalis as a Potent Allergen in House Dust and Its Role in Allergic Asthma in Kolkata Metropolis, India.

Authors:  Sanjoy Podder; Salil Kumar Gupta; Goutam Kumar Saha
Journal:  World Allergy Organ J       Date:  2010-05-07       Impact factor: 4.084

3.  Role of offending out-door aero-allergen and CD14 C(-159)T polymorphism in development and severity of asthma in a Kolkata patient population.

Authors:  Shampa Dutta; Priti Mondal; Nimai Chandra Saha; Saibal Moitra; Sanjoy Podder; Amlan Ghosh; Goutam Kumar Saha
Journal:  Afr Health Sci       Date:  2017-12       Impact factor: 0.927

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.